piperacillin has been researched along with magainin 1 peptide, xenopus in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cirioni, O; Del Prete, MS; Fineo, A; Ghiselli, R; Giacometti, A; Mocchegiani, F; Orlando, F; Rocchi, M; Saba, V; Scalise, G | 1 |
1 other study(ies) available for piperacillin and magainin 1 peptide, xenopus
Article | Year |
---|---|
Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Disease Models, Animal; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Infusions, Parenteral; Magainins; Male; Microbial Sensitivity Tests; Piperacillin; Rats; Rats, Wistar; Shock, Septic; Treatment Outcome; Xenopus Proteins | 2002 |